NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA has issued a draft local coverage determination for Natera's cell-free DNA-based kidney transplantation rejection test, Prospera, the company said today.
NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA has issued a draft local coverage determination for Natera's cell-free DNA-based kidney transplantation rejection test, Prospera, the company said today.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.